EHMT1 anticorps (truncated)

N° du produit ABIN2464057

Cet anticorps Souris Monoclonal détecte spécifiquement EHMT1 dans WB et ELISA. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour EHMT1 anticorps (truncated) (ABIN2464057)

Antigène: EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp EHMT1 est non-conjugé

Application: Western Blotting (WB), ELISA

Clone: 1B7B4

Détail du produit anti-EHMT1 anticorps

Épitope: truncated

Purification: Antibody is purified by protein A affinity chromatography.

Immunogène: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3).

Isotype: IgG1

Information d'application

Indications d'application: Western Blot:Dilution 1:500 - 1:2,000
ELISA:Propose dilution 1:10,000.
Determining optimal working dilutions by titration test.

Restrictions: For Research Use only

Stockage

Buffer: Purified antibody in PBS containing 0.03 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Stock: -20 °C

Stockage commentaire: GLP monoclonal antibody can be stored at -20 °C, stable for one year.

Détails sur EHMT1

Antigène: EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))

Autre désignation: GLP

Sujet: Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L cells in response to ingested nutrients. The closely related peptides glucagon-like peptide (GLP-1) and glucagon have opposing effects on blood glucose. GLP-1 induces glucose-dependent insulin secretion in the pancreas, while glucagon stimulates gluconeogenesis and glycogenolysis in the liver. Glucagon is processed from a large precursor, proglucagon, in a tissue-specific manner in pancreatic alpha-cells. The identification of a hybrid peptide acting as both a GLP-1 agonist and a glucagon antagonist would provide a novel approach for the treatment of type 2 diabetes.

ID gène: 79813

UniProt: Q9H9B1